
BACKGROUND
Co-sponsored by the MdBio Division of the TCM, the Virginia Biotechnol- ogy Association and the Mid Atlantic Venture Association, Mid-Atlantic Bio is the premier bioscience industry and investor conference in the region. The 2008 Mid-Atlantic Bio Conference brought together more than 850 national and international industry leaders, government representatives, executives, researchers, investors, entrepreneurs, and service providers—representing 30 states and 10 countries—in a unique forum to promote networking, business expansion, and technical-knowledge sharing.
EVENT SIZE: 850+ attendees.
MORE INFORMATION
Please contact us at info@midatlanticbio.org or 866.482.7691.
EVENT FREQUENCY
The Mid-Atlantic Bio is held once a year.
This year it will be held on November 4-6, 2009
lOCATION
Walter E. Washington Convention Center, Washington, DC
BENEFITS
Your support of this conference will provide you with the opportunity to network with national and international leaders in the life sciences industry, senior members of the current administration, members of Congress, and repre- sentatives from the diplomatic community. You will also receive significant visibility and marketing opportunities with more than 850 guests, including the region’s bioscience leaders, researchers, entrepreneurs, professional services firms and investors who gather together with global industry and scientific thought leaders to further the significant scientific and economic impact of the life sciences industry. last year we enjoyed the participation of more than 200 bioscience companies, from 30 states and 10 countries along with over 50 investor funds.
SPONSOR OPPORTUNITIES
Mid-Atlantic Bio is pleased to offer a wide range of sponsorship opportunities that will give your organization visibility, market exposure and added participant benefits. Past sponsors have told us that they have seen a favorable return from their sponsorship, both in heightening company visibility and by forming successful business contacts. 2008 Mid-Atlantic Bio sponsors reached an audience of more than 800 leaders of prominent life sciences companies, investment firms, academic institutions, and government agencies.